A bit ambiguous ...What do you mean by initial assays results the 1st drill hole the last one in phase 1 or phase 2 ? Assays results ... The Share price was hammered down to 34c due to MZN Legal action/challenge on ownership fo the Earl Grey deposit ... Not because of assays.
Conveniently there is a 3b immediately on after the KDR scoping Study results on 5 Oct 2017 Expect you should study that closely .
KDR Scoping Study presented on the 3 Oct 2017 Price 89.5c two weeks after scoping study it was 1.40c. No doubt taking in the good news of the study and Rerate factoring it into the price.
At time of scoping study then using say 90c we have 349 shares including escrow +47m Options which gives a mcap undiluted of $314m undiluted and $356m Mcap fully diluted.
If you take into account the rerate that happened post Pre feasibility (2 weeks after) then you have a price of 1.40 so 349 shares including escrow +47m Options which gives a mcap undiluted of $488m undiluted and $554m Mcap fully diluted.
So you roughy numbers from 1st post were quite accidentally understated. To suit your agenda.
Still the elephant in the room is the AVZ is likely to be many multiples in size of KDR.
AVZ Price at posting:
15.5¢ Sentiment: Buy Disclosure: Held
